Cure Parkinson’s Annual Pipeline Research Acceleration Programme

Funding for research that must be conducted before a therapy for Parkinson’s can move into the clinical trial stage.

Cure Parkinson’s is a patient-led charity with the aim of raising money to fund and facilitate research into finding a cure for Parkinson’s.

Each year the Cure Parkinson’s International Linked Clinical Trials (iLCT) committee ranks and prioritises candidate therapies based on whether they are ready to be taken into clinical trial for Parkinson’s. Some agents that are not prioritised to move into trial are found to demonstrate great potential but require further research before being tested in people with Parkinson’s.

The Pipeline Research funding call aims to accelerate the additional research required for therapeutic candidates evaluated by the iLCT committee that were not considered ready to move forward into clinical trials in people with Parkinson’s. The type of research covered by the programme may include preclinical, epidemiological, dose-finding, or target engagement research.

Every winter this programme will call for expressions of interest and subsequent applications for funding based on specified project outlines developed by Cure Parkinson’s from the iLCT committee feedback, to test one or more therapies that has been evaluated by iLCT but requires further research before moving into clinical trial. These project outlines will include details such as:

• The therapy (or therapies) to be tested.
• The type of models to be used.
• Any specific assessments to be included.
• Max project cost.
• Max project duration (typically 6-18 months).